Overall rank by patents
#38,920
Across all tracked assignees
USPTO 2015–2025 USPTO PatentsView US Corporation
Applied Cardiovascular Solutions, Llc
USPTO PatentsView assignee record - 6 granted patents across 3 technology areas, active 2020–2023. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61B (DIAGNOSIS; SURGERY; IDENTIFICATION).
6
Total patents granted
3
CPC technology areas
20.5
Avg claims per patent
-
5-year filing velocity
The verdict
Applied holds 6 US patents across 3 technology areas, rank #38,920 of 50,000 tracked assignees.
- #38,920
- of 50,000 US assignees by volume
- Top 73%
- by Innovation Score (28.5/100)
- 20.5
- avg claims per patent
Portfolio overview
Applied Cardiovascular Solutions, Llc has been granted 6 US utility patents between 2020 and 2023, placing Applied Cardiovascular Solutions, Llc at rank #38,920 across all assignees tracked by PlainPatent. This portfolio spans 3 distinct Cooperative Patent Classification (CPC) subclasses, averaging 20.5 claims per patent with primary concentration in A61B (DIAGNOSIS; SURGERY; IDENTIFICATION). As a US Corporation, Applied Cardiovascular Solutions, Llc is one of the more focused assignees in the PatentsView dataset. By volume, Applied sits between Appnexus Inc. (6 patents, rank #38,916) and Applied Physics, Inc. (6 patents, rank #38,924) - the closest US assignees by grant volume. The composite Innovation Score of 28.5/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Historical data spans 2020 through 2023, with 6 total grants over that period. Velocity comparisons require five years of historical filings to calibrate. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Applied Cardiovascular Solutions, Llc's 20.5 average claims per patent reflects complex, broadly scoped inventions that are difficult for competitors to design around, while specialization in 3 subclasses reflects a tightly scoped invention area. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Applied Cardiovascular Solutions, Llc against peers pursuing similar technology classes.
Who files at Applied's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Appnexus
AppNexus Inc.
6 patents
- Appario Global So…
Appario Global Solutions (AGS) AG
6 patents
- Appcelerator
Appcelerator, Inc.
6 patents
- Applied Biotechno…
Applied Biotechnology Institute, Inc.
6 patents
- Applied Electric…
Applied Electric Vehicles Pty Ltd
6 patents
- Applied Industrial
Applied Industrial Technologies, Inc.
6 patents
- Applied Nanotech
Applied Nanotech, Inc.
6 patents
- Applied Physics
Applied Physics, Inc.
6 patents
- Applied Cardiovas… ◀
Applied Cardiovascular Solutions, LLC
6 patents
What this shows Applied holds 6 patents at rank #38,920, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Applied
By rank, the assignees closest to #38,920 in granted patent volume.
- Appnexus Inc. #38,916 · 6 patents
- Appario Global Solutions (ags) Ag #38,917 · 6 patents
- Appcelerator, Inc. #38,918 · 6 patents
- Applied Biotechnology Institute, Inc. #38,919 · 6 patents
- Applied Electric Vehicles Pty Ltd #38,921 · 6 patents
- Applied Industrial Technologies, Inc. #38,922 · 6 patents
- Applied Nanotech, Inc. #38,923 · 6 patents
- Applied Physics, Inc. #38,924 · 6 patents
Leaders in A61B (Diagnosis)
Other assignees with the most granted patents in Applied's primary technology class.
- Covidien Lp 5,709 in class
- Koniniklijke Philips N.v. 3,414 in class
- Olympus Corporation 2,758 in class
- Boston Scientific Scimed, Inc. 2,362 in class
- Cilag Gmbh International 2,063 in class
- Intuitive Surgical Operations, Inc. 1,921 in class
- Depuy Synthes Products, Inc. 1,796 in class
- Ethicon, Inc. 1,762 in class
Applied's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
28 Top 73% higher than 27% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2020–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2020 | 3 | 50.0% |
| 2021 | 1 | 16.7% |
| 2022 | 1 | 16.7% |
| 2023 | 1 | 16.7% |
Which technologies does Applied Cardiovascular Solutions, Llc patent most?
Top 3 of 3 technology areas
Patent Moat Analysis
Portfolio Volume Light
Tech Breadth Specialized
Claim Depth Complex
Frequently Asked Questions
How many patents does Applied Cardiovascular Solutions, Llc hold?
Applied Cardiovascular Solutions, Llc holds 6 US granted patents filed between 2020 and 2023, spanning 3 technology areas.
What is Applied Cardiovascular Solutions, Llc's Innovation Score?
Applied Cardiovascular Solutions, Llc has an Innovation Score of 28.5 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does Applied Cardiovascular Solutions, Llc focus on?
Applied Cardiovascular Solutions, Llc's top technology area is A61B (DIAGNOSIS; SURGERY; IDENTIFICATION) with 6 patents. The company has filed patents in 3 CPC subclasses total.
Is Applied Cardiovascular Solutions, Llc's patent filing rate increasing or decreasing?
Insufficient historical data is available to calculate a velocity trend for Applied Cardiovascular Solutions, Llc.
What does claim depth mean for Applied Cardiovascular Solutions, Llc's patents?
Applied Cardiovascular Solutions, Llc's patents average 20.5 claims each. This indicates complex, broadly scoped patents that are harder for competitors to design around.
How is the Applied Cardiovascular Solutions, Llc patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.
How to use this portfolio
Applied's 6 grants land it in the top 73% by Innovation Score, but volume alone doesn't tell you where the strength sits.
- Read that count against the largest US assignees before treating it as dominance - Applied ranks #38,920 of 50,000. Top 50 holders
- Most of this portfolio concentrates in A61B - see who else leads that technology area. A61B leaders
- Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.